Howard Bradley Schiller is Chairman at Valeant Pharmaceuticals International, Inc. (VRX). They have made 6 open-market trades across 1 company since 2011, most recently 2016-02-18.
CIK 0001536053
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
6 open-market purchases totalling $5.0M since 2011, never a sale. Across 6 scored buys the stock is up 0.4% at ninety days, and 0.2 points ahead of the S&P over the same stretch.
6 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| VRX | 336,784 | $7.9M |
Shares reported on the most recent Form 4, priced at the 2016-02-22 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 0% | 100% | 100% |
| Avg Move | -12.8% | +0.4% | +0.4% |
| Alpha | -7.0% | +0.2% | +0.2% |
| Scored | 6 | 6 | 6 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| VRX | BUY | 2012-11-06 | 2012-11-08 | $54.10 | $990K | -12.8% | +0.4% | +0.4% |
| VRX | BUY | 2012-03-06 | 2012-03-08 | $53.53 | $492K | -12.8% | +0.4% | +0.4% |
| VRX | BUY | 2012-03-01 | 2012-03-05 | $53.64 | $998K | -12.8% | +0.4% | +0.4% |
| VRX | BUY | 2011-12-08 | 2011-12-09 | $45.51 | $501K | -12.8% | +0.4% | +0.4% |
| VRX | BUY | 2011-12-05 | 2011-12-07 | $46.82 | $515K | -12.8% | +0.4% | +0.4% |
| VRX | BUY | 2011-12-01 | 2011-12-05 | $46.12 | $1.5M | -12.8% | +0.4% | +0.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.